Pharma Reviews: Piramal enterprises looks to sell 20% equity in healthcare business

After selling its India pharma business to US drug maker Abbott for Rs 17,000 crore a decade ago and expanding to sectors such as real estate and ...
Read more: Piramal enterprises looks to sell 20% equity in healthcare business